| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |